Back

Development and validation of a nomogram predicting all-cause mortality for patients with an implantable cardioverter-defibrillator

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Recent advances in implantable cardioverter defibrillator therapy and remote monitoring Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Bin Zhou

Fuwai Hospital Chinese Academy of Medical Sciences Shenzhen, Shenzhen (China)

6 More presentations in this session

Presentation thumbnail
Lead placement in extravascular ICD recipients: the first step to prevent P-wave oversensing.
Doctor A. Quaranta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Periodic Repolarization Dynamics (PRD) identifies patients who profit from ICD implantation, A meta-analysis of the predictive value of PRD
Miss L. Sams (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Intermuscular placement and defibrillation with the extravascular ICD: a single-centre experience
Doctor A. Carecci (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Risk prediction of inappropriate implantable cardioverter-defibrillator therapy using machine learning
Doctor R. Tateishi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Mortality and appropriate therapies in ischaemic ICD recipients according to the electrophysiological study
Doctor N. Teodorovich (Rehovot, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Recent advances in implantable cardioverter defibrillator therapy and remote monitoring

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources